跳至主要内容
临床试验/NCT04234009
NCT04234009终止不适用

The Effects of a Healthy Lifestyle Intervention on Brain Vascular Function in Older People

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2020年1月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
10
试验地点
1
主要终点
Brain vascular function

研究概览

简要总结

Cognitive performance is negatively related to an impaired glucose metabolism, possibly due to impairments in brain vascular function. Supported by the statement from the American Heart and Stroke Association that a healthy lifestyle is one of the most effective strategies to protect against cognitive decline, the investigators now hypothesise that healthy lifestyle intervention-induced changes in glucose metabolism cause beneficial effects on brain vascular function thereby improving cognitive performance. The primary objective of this intervention study is thus to evaluate in sedentary older men and women the effect of a 16-week aerobic-based exercise program on cerebral blood flow, as quantified by the non-invasive gold standard magnetic resonance imaging (MRI) perfusion method Arterial Spin Labeling (ASL). Cerebral blood flow is a robust and sensitive physiological marker of brain vascular function. Secondary objectives are to examine effects on glucose metabolism using the homeostatic model assessment for insulin resistance (HOMA-ir) and cognitive performance as assessed with a neurophysiological test battery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
55 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •BMI between 25-35 kg/m2
  • •Sedentary (assessed as low physically active using the International Physical Activity Questionnaire)
  • •Right handedness and footedness
  • •Fasting plasma glucose < 7.0 mmol/L
  • •Fasting serum total cholesterol < 8.0 mmol/L
  • •Fasting serum triacylglycerol < 4.5 mmol/L
  • •Systolic blood pressure < 160 mmHg and diastolic blood pressure < 100 mmHg
  • •Stable body weight (weight gain or loss < 3 kg in the past three months)
  • •Willingness to give up being a blood donor from 8 weeks before the start of the study, during the study and for 4 weeks after completion of the study
  • •No difficult venipuncture as evidenced during the screening visit

排除标准

  • •Current smoker, or smoking cessation < 12 months
  • •Diabetic patients
  • •Familial hypercholesterolemia
  • •Abuse of drugs
  • •Consumption of more than 21 alcoholic units/week (men), or more than 14 alcoholic units/week (women)
  • •Use of dietary supplements known to interfere with the main study outcomes as judged by the principal investigators
  • •Use medication to treat blood pressure, lipid or glucose metabolism
  • •Use of an investigational product within another biomedical intervention trial within the previous 1-month
  • •Severe medical conditions that might interfere with the study, such as epilepsy, asthma, kidney failure or renal insufficiency, chronic obstructive pulmonary disease, inflammatory bowel diseases, auto inflammatory diseases and rheumatoid arthritis
  • •Active cardiovascular disease like congestive heart failure or cardiovascular event, such as an acute myocardial infarction or cerebrovascular accident
  • •Contra-indications for MRI imaging, including permanent facial makeup, surgical clips/material in body, metal splinter in eye or claustrophobia

研究组 & 干预措施

Healthy lifestyle

Experimental

Healthy lifestyle intervention, which includes physical activity and dietary advice according to the dutch guidelines.

干预措施: Healthy Lifestyle (Other)

Control

No Intervention

Maintenance of habitual physical activity and diet

结局指标

主要结局

Brain vascular function

时间窗: After intervention (16 weeks)

Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL)

Brain vascular function

时间窗: Baseline (0 weeks)

Cerebral blood flow as quantified non-invasively by the MRI perfusion method Arterial Spin Labeling (ASL)

次要结局

  • Cognitive performance(Baseline (0 weeks) and after intervention (16 weeks))
  • Glucose metabolism(Baseline (0 weeks), at the middle (8 weeks) and after intervention (16 weeks))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验